Imatinib Mesylate Tablets 100mg, packaged as a) 90-count bottles (NDC 43598-344-90); and b) For I...

FDA Drug Recall #D-0287-2021 — Class II — February 17, 2021

Recall Summary

Recall Number D-0287-2021
Classification Class II — Moderate risk
Date Initiated February 17, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Dr. Reddy's Laboratories, Inc.
Location Princeton, NJ
Product Type Drugs
Quantity a) 1350 bottles; b) 147 cartons

Product Description

Imatinib Mesylate Tablets 100mg, packaged as a) 90-count bottles (NDC 43598-344-90); and b) For Institutional Use Only 30-count (3 x 10 unit-dose) tablets per carton (NDC 43598-344-31); Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540; Made in India.

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lot #: a) H2000206, Exp 06/22; b) H2000138, Exp 06/22

Other Recalls from Dr. Reddy's Laboratories, Inc.

Recall # Classification Product Date
D-0219-2026 Class III Varenicline Tablets, 1mg, 56 Tablets, Rx only, ... Nov 11, 2025
D-0008-2026 Class II Succinylcholine Chloride Injection, USP, 200 mg... Sep 26, 2025
D-0525-2025 Class II Omeprazole Delayed-release Capsules, USP, 20mg,... Jun 30, 2025
D-0365-2025 Class I Levetiracetam 0.75% in Sodium Chloride Injectio... Mar 13, 2025
D-0117-2025 Class III Javygtor (sapropterin dihydrochloride) Tablets ... Nov 22, 2024

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.